The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Patterns of Psychotropic Drug Prescription for U.S. Patients With Diagnoses of Bipolar Disorders
Open accessAbstract
OBJECTIVE: Bipolar disorders are prevalent major illnesses with high rates of morbidity, comorbidity, disability, and mortality. A growing number of psychotropic drugs are used to treat bipolar disorder, often off-label and in untested, complex combinations. METHODS: To quantify utilization rates for psychotropic drug classes, this study used the 2002-2003 U.S. national MarketScan research databases to identify 7,760 persons with ICD-9 bipolar disorder subtypes. Survival analysis was used to estimate times until initial monotherapies were augmented, changed, or discontinued. RESULTS: The most commonly prescribed first drug class was antidepressants (50% of patients), followed by mood stabilizers (25%: anticonvulsants, 17%, and lithium, 8%), sedatives (15%), and antipsychotics (11%). At study midpoint only 44% of patients were receiving monotherapy. Those receiving monotherapy were ranked by initial drug prescribed and percentage of patients (bipolar I and bipolar II): antidepressants (55% and 65%), lithium (51% and 41%), antipsychotics (32% and 31%), anticonvulsants (28% and 29%), and sedatives (28%, 25%). Median time to adding another psychotropic was 2.5-times less than median time to changing the initial treatment (16.4 compared with 40.9 weeks), and stopping was rare. Median weeks until therapy was changed in any way for 25% of patients was as follows: lithium, 29 weeks; antidepressants, 13; anticonvulsants, 13; antipsychotics, 13; and sedatives, 9. CONCLUSIONS: Antidepressants were the first-choice agent twice as often as mood stabilizers. Lithium was sustained longer than monotherapy with other mood stabilizers. Time to augmentation was much shorter than time to change or discontinuation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Kessler, R. C., Chiu, W. T., Demler, O., & Walters, E. E. (2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.6.617 · Cited by 12,052
(1984) · The Lancet · doi:10.1016/s0140-6736(84)92810-1 · Cited by 2,925
The Long-term Natural History of the Weekly Symptomatic Status of Bipolar I Disorder
Judd, L. L., Akiskal, H. S., Schettler, P. J., Endicott, J., Maser, J., Solomon, D. A., Leon, A. C., Rice, J. A., & Keller, M. B. (2002) · Archives of General Psychiatry · doi:10.1001/archpsyc.59.6.530 · Cited by 2,106
Goodman and Gilman's the Pharmacological Basis of Therapeutics
Thompson Coon, J. (2002) · Focus on Alternative and Complementary Therapies · doi:10.1111/j.2042-7166.2002.tb05480.x · Cited by 1,744
Judd, L. L., Akiskal, H. S., Schettler, P. J., Coryell, W., Endicott, J., Maser, J. D., Solomon, D. A., Leon, A. C., & Keller, M. B. (2003) · Archives of General Psychiatry · doi:10.1001/archpsyc.60.3.261 · Cited by 1,243
Decreased risk of suicides and attempts during long‐term lithium treatment: a meta‐analytic review
Baldessarini, R. J., Tondo, L., Davis, P., Pompili, M., Goodwin, F. K., & Hennen, J. (2006) · Bipolar Disorders · doi:10.1111/j.1399-5618.2006.00344.x · Cited by 753
Self-citationPerlis, R. H., Ostacher, M. J., Patel, J. K., Marangell, L. B., Zhang, H., Wisniewski, S. R., Ketter, T. A., Miklowitz, D. J., Otto, M. W., Gyulai, L., et al. (2006) · American Journal of Psychiatry · doi:10.1176/appi.ajp.163.2.217 · Cited by 689
Mathur, R. (2004) · Drug Screening Methods · doi:10.5005/jp/books/10243_6 · Cited by 665
Cipriani, A., Pretty, H., Hawton, K., & Geddes, J. R. (2005) · American Journal of Psychiatry · doi:10.1176/appi.ajp.162.10.1805 · Cited by 617
Judd, L. L., Akiskal, H. S., Schettler, P. J., Endicott, J., Leon, A. C., Solomon, D. A., Coryell, W., Maser, J. D., & Keller, M. B. (2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.12.1322 · Cited by 577
The McLean-Harvard First-Episode Mania Study: Prediction of Recovery and First Recurrence
Tohen, M., Zarate, C. A., Hennen, J., Khalsa, H.-M. K., Strakowski, S. M., Gebre-Medhin, P., Salvatore, P., & Baldessarini, R. J. (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.12.2099 · Cited by 471
Self-citationPost, R. M., Denicoff, K. D., Leverich, G. S., Altshuler, L. L., Frye, M. A., Suppes, T. M., Rush, A. J., Keck, P. E., McElroy, S. L., Luckenbaugh, D. A., et al. (2003) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v64n0610 · Cited by 418
Suicidal Behaviour in Bipolar Disorder: Risk and Prevention
Tondo, L., Isacsson, G., & Baldessarini, R. J. (2003) · CNS Drugs · doi:10.2165/00023210-200317070-00003 · Cited by 402
Self-citationAntidepressants in bipolar disorder: the case for caution
Ghaemi, S. N., Hsu, D. J., Soldani, F., & Goodwin, F. K. (2003) · Bipolar Disorders · doi:10.1046/j.1399-5618.2003.00074.x · Cited by 393
The Increasing Use of Polypharmacotherapy for Refractory Mood Disorders: 22 Years of Study
Frye, M. A., Ketter, T. A., Leverich, G. S., Huggins, T., Lantz, C., Denicoff, K. D., & Post, R. M. (2000) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v61n0104 · Cited by 315
Antipsychotic Drugs: A New Risk Factor for Osteoporosis in Young Women With Schizophrenia?
O'Keane, V., & Meaney, A. M. (2005) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000150223.31007.e0 · Cited by 307
Antidepressant Treatment in Bipolar Versus Unipolar Depression
Ghaemi, S. N., Rosenquist, K. J., Ko, J. Y., Baldassano, C. F., Kontos, N. J., & Baldessarini, R. J. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.1.163 · Cited by 270
Self-citationCentorrino, F., Goren, J. L., Hennen, J., Salvatore, P., Kelleher, J. P., & Baldessarini, R. J. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.4.700 · Cited by 253
Self-citationEpidemiology of Bipolar Disorders
Bauer, M., & Pfennig, A. (2005) · Epilepsia · doi:10.1111/j.1528-1167.2005.463003.x · Cited by 199
Lithium Treatment and Risk of Suicidal Behavior in Bipolar Disorder Patients
Tondo, L., Baldessarini, R. J., Hennen, J., Floris, G., Silvetti, F., & Tohen, M. (1998) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v59n0802 · Cited by 177
Self-citationJoffe, R. T., MacQueen, G. M., Marriott, M., & Trevor Young, L. (2004) · Bipolar Disorders · doi:10.1046/j.1399-5618.2003.00091.x · Cited by 172
A plea for integrity of the bipolar disorder concept
Baldessarini, R. J. (2000) · Bipolar Disorders · doi:10.1034/j.1399-5618.2000.020102.x · Cited by 161
Self-citationAltshuler, L. L., Suppes, T. M., Black, D. O., Nolen, W. A., Leverich, G. S., Keck, P. E., Frye, M. A., Kupka, R., McElroy, S. L., Grunze, H., et al. (2006) · American Journal of Psychiatry · doi:10.1176/appi.ajp.163.2.313 · Cited by 155
Pediatric-Onset Bipolar Disorder: A Neglected Clinical and Public Health Problem Gianni
Faedda, L., Baldessarini, R. J., Suppes, T. M., Tondo, L., Becker, I., & Lipschitz, D. S. (1995) · Harvard Review of Psychiatry · doi:10.3109/10673229509017185 · Cited by 150
Self-citationMisdiagnosed Patients With Bipolar Disorder
Matza, L. S., Rajagopalan, K., Thompson, C. L., & de Lissovoy, G. (2005) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v66n1114 · Cited by 137
Tondo, L., Baldessarini, R. J., & Floris, G. (2001) · British Journal of Psychiatry · doi:10.1192/bjp.178.41.s184 · Cited by 132
Self-citationAkiskal, H. S., & Benazzi, F. (2005) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v66n0715 · Cited by 130
(1951) · Tubercle · doi:10.1016/s0041-3879(51)80130-2 · Cited by 125
Recent Antihyperglycemic Prescribing Trends for U.S. Privately Insured Patients With Type 2 Diabetes
Cohen, F. J., Neslusan, C. A., Conklin, J. E., & Song, X. (2003) · Diabetes Care · doi:10.2337/diacare.26.6.1847 · Cited by 102
Polytherapy in Bipolar Disorder
Lin, D., Mok, H., & Yatham, L. N. (2006) · CNS Drugs · doi:10.2165/00023210-200620010-00003 · Cited by 91
Is Lithium Still Worth Using? An Update of Selected Recent Research
Baldessarini, R. J., Tondo, L., Hennen, J. A., & Viguera, A. C. (2002) · Harvard Review of Psychiatry · doi:10.1080/10673220216208 · Cited by 85
Self-citationProphylaxis Latency and Outcome in Bipolar Disorders
Baethge, C., Tondo, L., Bratti, I. M., Bschor, T., Bauer, M., Viguera, A. C., & Baldessarini, R. J. (2003) · The Canadian Journal of Psychiatry · doi:10.1177/070674370304800704 · Cited by 76
Self-citationBipolar Depression in a Low-Income Primary Care Clinic
Olfson, M., Das, A. K., Gameroff, M. J., Pilowsky, D. J., Feder, A., Gross, R., Lantigua, R., Shea, S. A., & Weissman, M. M. (2005) · American Journal of Psychiatry · doi:10.1176/appi.ajp.162.11.2146 · Cited by 66
Ghaemi, S. N. (2002) · doi:10.1201/b15278 · Cited by 48
Bipolar disorder, antidepressants and induction of hypomania or mania. A systematic review
Visser, H. M., & van der Mast, R. C. (2005) · The World Journal of Biological Psychiatry · doi:10.1080/15622970510029885 · Cited by 47
Baethge, C., Baldessarini, R. J., Mathiske-Schmidt, K., Hennen, J. A., Berghöfer, A., Müller-Oerlinghausen, B., Bschor, T., Adli, M., & Bauer, M. (2005) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v66n0204 · Cited by 46
Self-citationAntipsychotic drug use: McLean Hospital, 2002
Centorrino, F., Fogarty, K. V., Sani, G., Salvatore, P., Cimbolli, P., & Baldessarini, R. J. (2005) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.700 · Cited by 43
Self-citationThe Manic-Depressive Spectrum and Mood Stabilization: Kraepelin’s Ghost
Ghaemi, S. N., & Baldessarini, R. J. (2007) · Psychotherapy and Psychosomatics · doi:10.1159/000097964 · Cited by 30
Self-citationHarpaz‐Rotem, I., & Rosenheck, R. A. (2006) · Child Care Health and Development · doi:10.1111/j.1365-2214.2006.00588.x · Cited by 30
Cited by
Yatham, L. N., Kennedy, S. H., Parikh, S. V., Schaffer, A., Beaulieu, S., Alda, M., O’Donovan, C., MacQueen, G., McIntyre, R. S., Sharma, V., et al. (2013) · Bipolar Disorders · doi:10.1111/bdi.12025 · Cited by 1,217
Yatham, L. N., Kennedy, S. H., Schaffer, A., Parikh, S. V., Beaulieu, S., O'Donovan, C., MacQueen, G., McIntyre, R. S., Sharma, V., Ravindran, A., et al. (2009) · Bipolar Disorders · doi:10.1111/j.1399-5618.2009.00672.x · Cited by 570
McElroy, S. L., Weisler, R. H., Chang, W., Olausson, B., Paulsson, B., Brecher, M., Agambaram, V., Merideth, C., Nordenhem, A., Young, A. H., et al. (2010) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.08m04942gre · Cited by 328
Neurocognitive impairment in bipolar disorder patients: functional implications
Wingo, A. P., Harvey, P. D., & Baldessarini, R. J. (2009) · Bipolar Disorders · doi:10.1111/j.1399-5618.2009.00665.x · Cited by 274
Self-citationMania associated with antidepressant treatment: comprehensive meta‐analytic review
Tondo, L., Vázquez, G., & Baldessarini, R. J. (2010) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2009.01514.x · Cited by 256
“Whatever its interpretation, our findings concerning mood-stabilizer co-treatment with an AD does not support the prevalent clinical impression that these drugs effectively limit risk of mania, at least among type I BPD patients, including many who are exposed to ADs (12, 103, 106, 107).”
ResultSelf-citation
Metadata
- Authors
- Baldessarini, R. J., Leahy, L., Arcona, S., Gause, D., Zhang, W., & Hennen, J.
- Venue
- Psychiatric Services
- Published
- 2007-01
- Volume
- 58
- Issue
- 1
- Pages
- 85-91
- ISSN
- 0022-1597 (ISSN-L)
- 1075-2730
- 1557-9700
- OpenAlex
- W2115503446
- Cited by
- 280
- References
- 39
- FWCI
- 11.10
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.